Clinical Trial Update: COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable

View source ↗

Summary

An update on an ongoing trial evaluating the COR ECG wearable, powered by AI, to optimize cardiovascular and cardiopulmonary outcomes across multiple conditions…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Cardiomyopathy
• Heart Failure
• Ischemic Heart Disease
• Myocardial Infarction
• Stroke
• Syncope

Drugs mentioned

• COR ECG Wearable

Snippet

Sponsor: Peerbridge Health, Inc | Conditions: Cardiopulmonary Failure, Myocardial Infarction (MI) | Status: ENROLLING_BY_INVITATION